Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.10% | $570.26K | €465.10B | 75.38% | 76 Outperform | |
| AstraZeneca | 1.65% | $303.64K | £215.20B | 20.26% | 80 Outperform | |
| Roche Holding AG | 1.63% | $300.54K | CHF279.71B | 44.52% | 73 Outperform | |
| Novartis AG | 1.46% | $268.00K | CHF221.76B | 22.22% | 80 Outperform | |
| HSBC Holdings | 1.20% | $220.19K | £219.36B | 50.59% | 80 Outperform | |
| Shell (UK) | 1.18% | $217.36K | £152.85B | 5.30% | 73 Outperform | |
| Banco Bilbao Vizcaya Argentaria | 1.09% | $200.07K | €123.17B | 90.74% | 76 Outperform | |
| SAP SE | 1.06% | $194.59K | €222.64B | -27.00% | 66 Neutral | |
| Mitsubishi UFJ Financial Group | 1.06% | $194.44K | ¥30.99T | 46.36% | 76 Outperform | |
| Siemens | 1.01% | $185.48K | €197.72B | 23.31% | 74 Outperform |